74386-55-3

Basic information

• Product Name: 5-(benzyloxy)picolinic acid
• Synonyms: 5-(benzyloxy)picolinic acid;5-(benzyloxy)pyridine-2-carboxylic acid;2-Pyridinecarboxylic acid, 5-(phenylmethoxy)-
• CAS NO: 74386-55-3
• Molecular Formula: C₁₃H₁₁NO₃
• Molecular Weight: 229.23134
• Mol File: 74386-55-3.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-(benzyloxy)picolinic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(benzyloxy)picolinic acid(74386-55-3)
• EPA Substance Registry System: 5-(benzyloxy)picolinic acid(74386-55-3)

Safety Data

• Hazardous Substances Data: 74386-55-3(Hazardous Substances Data)

Upstream product

• 59781-08-7 5-benzyloxypyridin-2-carbaldehyde 
• 63793-98-6 5-benzyloxy-2-methyl-pyridine 
• 74386-59-7 5-benzyloxy-2-pyridinecarboxylic acid methyl ester 

Downstream Products

• 787564-19-6 2-[(5-benzyloxypyridine-2-carbonyl)amino]malonic acid dimethyl ester 
• 362699-65-8 5-(benzyloxy)-N-{4-[2-(hydroxyamino)-2-oxoethyl]-4-piperidinyl}-2-pyridinecarboxamide trifluoroacetate 
• 858602-75-2 5-benzyloxypyridine-2-carboxylic acid N-methoxy-N-methylamide 
• 1208536-57-5 C₁₅H₁₆N₂O₂ 
• 1208536-50-8 2-(azetidin-1-ylcarbonyl)-5-(benzyloxy)pyridine 
• 1208536-60-0 C₁₅H₁₆N₂O₂ 

Relevant articles and documents

OXOTETRAHYDROFURAN-2-YL-BENZIMIDAZOLE DERIVATIVE

The present invention relates to compounds, which are useful for treatment and/or prevention of diabetes mellitus, diabetes mellitus complications or obesity, since the compounds have glucokinase-activating effects, and are presented in Formula (I): wherein R1 represents a carbamoyl group; R2 represents a lower alkyl group; both of X1 and X2 represent CH, or any one of X1 and X2 represents a nitrogen atom and the other represents CH; a group of represents a group selected from the group consisting of a pyridinyl, a pyrazinyl, a pyrazolyl, a thiadiazolyl, a triazolyl, an isoxazolyl and a thiazolyl group; and k is zero or 1, or relates to pharmaceutically acceptable salts thereof.

1,5-DIHETEROCYCLE-1H-TRIAZOLE DERIVATIVE

The present invention relates to a compound represented by Formula (I): wherein Ar1, Ar2, R1 and R2 each represent a substituent, a salt thereof, or a solvate of the compound or the salt, and to a medicine containing the same. According to the present invention, a potent platelet aggregation suppressant which does not inhibit COX-1 and COX-2 is provided.

AMIDOPYRAZOLE DERIVATIVE

A platelet coagulation inhibitor which inhibits neither COX-1 nor COX-2 is provided. The inhibitor is a compound represented by general formula (I): wherein Ar1 and Ar2 independently represent a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents, or a phenyl group optionally substituted with 1 to 3 substituents; R1 represents a lower acyl group, carboxyl group, a lower alkoxycarbonyl group, a lower alkoxy group, a lower alkyl group optionally substituted with 1 or 2 substituents, a carbamoyl group optionally substituted with 1 or 2 substituents, an oxamoyl group optionally substituted with 1 or 2 substituents, an amino group optionally substituted with 1 or 2 substituents, a 4- to 7-membered alicyclic heterocyclic group optionally substituted with 1 or 2 substituents, a phenyl group optionally substituted with 1 to 3 substituents, or a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents; and R2 represents hydrogen atom, a halogeno group, or the like.